Investigating the benefits of prone position radiotherapy for breast cancer patients
A Comparison of Three Radiotherapy Techniques for Breast Cancer: a Planning Study
This study is testing if giving radiotherapy to breast cancer patients while lying face down can better protect their heart and lungs compared to the usual face-up position.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Sex | Female |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT01284153 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the advantages of administering radiotherapy to breast cancer patients while they are in a prone position, as opposed to the standard supine position. The focus is on comparing the radiation doses received by critical organs, such as the heart and lungs, using both techniques. By analyzing these differences, the study seeks to determine if the prone position offers any significant benefits in terms of organ protection during treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are breast cancer patients who require radiotherapy for their condition.
Not a fit: Patients who do not require radiotherapy or have contraindications for the treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved safety and reduced side effects for breast cancer patients undergoing radiotherapy.
How similar studies have performed: While this specific approach is being investigated, similar studies have shown promising results in reducing radiation exposure to organs at risk in other cancer treatments.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * indication for radiotherapy of the breast and /or lymph nodes Exclusion Criteria: * none ( planning study)
Where this trial is running
Leuven
- UZ Leuven Radiotherapy Department — Leuven, Belgium (Recruiting)
Study contacts
- Study coordinator: Caroline Sweldens, Doctor
- Email: caroline.sweldens@uzleuven.be
- Phone: 003216347600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.